Physician profile
Samir A Hadeed
NPI 1023045523
$79,865.27
in general payments reported to CMS, 2019-2025
58 companies · $1,454 in 2025
The $1,454 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $7,112 · 2021: $13K · 2022: $26K · 2023: $1,813 · 2024: $2,885 · 2025: $1,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,071 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,070.79 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $64,840.96 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,493.52 | 2019-2025 | Lifevest |
| Philips North America LLC | $1,348.26 | 2019-2023 | |
| Medtronic, INC. | $1,238.95 | 2021-2025 | Resolute Onyx, Ffrangio, Symplicity G3 |
| E.R. Squibb & Sons, L.L.C. | $1,113.48 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,019.00 | 2019-2025 | Jardiance |
| Amgen INC. | $999.75 | 2019-2025 | Repatha, Repatha, Otezla |
| Pfizer INC. | $966.47 | 2019-2025 | |
| Abbott Laboratories | $702.06 | 2019-2025 | Jot Dx, Aveir, Allure Quadra |
| Astrazeneca Pharmaceuticals LP | $577.18 | 2019-2024 | Brilinta, Farxiga |
| Novartis Pharmaceuticals Corporation | $545.45 | 2019-2025 | |
| Boston Scientific Corporation | $531.45 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Amarin Pharma, INC. | $427.39 | 2019-2021 | |
| Irhythm Technologies, INC. | $411.48 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Merck Sharp & Dohme LLC | $401.32 | 2021-2025 | Verquvo, Capvaxive |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $305.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Medline Industries LP | $261.69 | 2019 | |
| Angiodynamics, INC. | $253.84 | 2020-2024 | Auryon Laser System 100-120 Vac |
| Actelion Pharmaceuticals US, INC. | $210.17 | 2021-2022 | |
| Biotronik INC. | $190.94 | 2019-2025 | Biomonitor |
| Kowa Pharmaceuticals America, INC. | $188.97 | 2020-2022 | |
| Esperion Therapeutics, INC. | $157.85 | 2020-2024 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $151.14 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $114.10 | 2023-2025 | |
| Medicomp INC | $111.67 | 2023-2025 | Telepatch Cardiac Monitor |
| Vifor Pharma, INC. | $107.59 | 2020-2022 | |
| Tactile Systems Technology INC | $99.68 | 2020-2024 | Entre Plus, Flexitouch Plus |
| Astellas Pharma US INC | $99.50 | 2019-2022 | |
| Shockwave Medical, INC | $98.26 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $78.64 | 2019-2021 | |
| Terumo Medical Corporation | $72.73 | 2019-2022 | |
| Opsens INC. | $59.15 | 2019 | |
| Getinge USA Sales, LLC | $50.26 | 2019 | |
| Impulse Dynamics (USA) INC. | $48.01 | 2023 | Optimizer |
| Bridgebio Pharma, INC. | $45.85 | 2025 | Attruby |
| Regeneron Healthcare Solutions, INC. | $45.68 | 2019 | |
| Cardiovascular Systems INC. | $42.61 | 2019-2020 | |
| Atricure, INC. | $35.36 | 2023 | |
| Lilly USA, LLC | $35.35 | 2020-2021 | |
| Stryker Corporation | $33.54 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bardy Diagnostics, INC. | $32.50 | 2020-2021 | |
| Preventice Services, LLC | $29.80 | 2021 | |
| Acist Medical Systems, INC. | $28.97 | 2025 | |
| Bard Peripheral Vascular, INC. | $26.57 | 2019 | |
| Becton, Dickinson and Company | $22.53 | 2023 | Fluency Endovascular Stent Graft |
| Inari Medical, INC. | $20.46 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Watermark Medical, INC. | $18.39 | 2025 | |
| Lundbeck LLC | $17.91 | 2020 | |
| Siemens Medical Solutions USA, INC. | $17.71 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Cardiva Medical, INC. | $16.71 | 2021 | |
| Azurity Pharmaceuticals, INC. | $16.55 | 2023 | Edarbi |
| W. L. Gore & Associates, INC. | $16.00 | 2022 | |
| Kestra Medical Technology Services, INC. | $15.97 | 2022 | |
| Amryt Pharma Holdings LTD | $14.49 | 2021 | |
| Baxter Healthcare | $14.37 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Abbvie INC. | $14.23 | 2019 | |
| Glaxosmithkline, LLC. | $13.85 | 2025 | Arexvy, Trelegy Ellipta |
| Biohaven Pharmaceutical Holding Company LTD. | $13.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Hadeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.